<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Trials</journal-id><journal-id journal-id-type="iso-abbrev">Trials</journal-id><journal-title-group><journal-title>Trials</journal-title></journal-title-group><issn pub-type="epub">1745-6215</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29673375</article-id><article-id pub-id-type="pmc">5907695</article-id><article-id pub-id-type="publisher-id">2630</article-id><article-id pub-id-type="doi">10.1186/s13063-018-2630-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Stages of behavioural change after direct-to-consumer disease risk profiling: study protocol of two integrated controlled pragmatic trials</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4451-6012</contrib-id><name><surname>Stewart</surname><given-names>Kelly F. J.</given-names></name><address><email>k.stewart@maastrichtuniversity.nl</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wesselius</surname><given-names>Anke</given-names></name><address><email>anke.wesselius@maastrichtuniversity.nl</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Schols</surname><given-names>Annemie M. W. J.</given-names></name><address><email>a.schols@maastrichtuniversity.nl</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Zeegers</surname><given-names>Maurice P.</given-names></name><address><email>m.zeegers@maastrichtuniversity.nl</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0481 6099</institution-id><institution-id institution-id-type="GRID">grid.5012.6</institution-id><institution>Department of Complex Genetics, NUTRIM School of Nutrition and Translational Research in Metabolism, </institution><institution>Maastricht University, </institution></institution-wrap>Maastricht, The Netherlands </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0481 6099</institution-id><institution-id institution-id-type="GRID">grid.5012.6</institution-id><institution>Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, </institution><institution>Maastricht University, </institution></institution-wrap>Maastricht, The Netherlands </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0481 6099</institution-id><institution-id institution-id-type="GRID">grid.5012.6</institution-id><institution>CAPHRI School for Public Health and Primary Care, </institution><institution>Maastricht University, </institution></institution-wrap>Maastricht, The Netherlands </aff></contrib-group><pub-date pub-type="epub"><day>19</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>19</volume><elocation-id>240</elocation-id><history><date date-type="received"><day>8</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>6</day><month>4</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">The incidence and prevalence of chronic diseases have reached epidemic proportions during the last decades and are not expected to diminish. Chronic diseases increasingly affect younger individuals too, with over 40% of all deaths due to non-communicable diseases occurring before the age of 70. This has led to the development of information services aimed at preventive health care, such as <italic>Health Potential&#x000ae;</italic>. This counselling service estimates a personal disease risk of a carefully selected list of preventable common chronic diseases that have both a genetic and a lifestyle component of development. The results are delivered face-to-face by a lifestyle counsellor, simultaneously stimulating initial steps towards behaviour change. This information can assist in lifestyle decision-making.</p></sec><sec><title>Methods/design</title><p id="Par2">The primary aim is to study the effect of the Health Potential&#x000ae; service on change in lifestyle behaviour in distinguishable customer populations. The secondary aims are (1) to study the effect of the Health Potential&#x000ae; service on determinants of behaviour change, (2) to study the effect of additional lifestyle counselling on behaviour change and determinants thereof, and (3) to describe the characteristics of the Health Potential&#x000ae; customer. The study consists of two integrated designs: (A) a two-armed non-randomised controlled pre-test/post-test trial (1.5:1 ratio), followed by (B) a two-armed randomised controlled pre-test/post-test trial (1:1 ratio), resulting in three study arms. Participants are clients of local prevention clinics, purchasing a personalised health check (PHC; intervention condition), consisting of Health Potential&#x000ae; and a general health check, or the general health check alone (GHC; control condition) (part A). PHC participants will be randomised to receive four additional lifestyle counselling sessions over a period of 3&#x000a0;months (part B).</p></sec><sec><title>Discussion</title><p id="Par3">This research can provide valuable insights into the effectiveness of and possible ways forward in the field of personalised prevention making use of lifestyle interventions enriched with modern genetic advancements.</p></sec><sec><title>Trial registration</title><p id="Par4">Nederlands Trial Register, <ext-link ext-link-type="uri" xlink:href="http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=6289">NTR6289</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=6288">NTR6288</ext-link>. Registered on 24 February 2017.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1186/s13063-018-2630-7) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Personalised medicine</kwd><kwd>Personalised prevention</kwd><kwd>Trials</kwd><kwd>Direct-to-consumer genetics</kwd><kwd>Lifestyle epidemiology</kwd><kwd>Genetic epidemiology</kwd><kwd>Community genetics</kwd><kwd>Health promotion</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par11">The incidence and prevalence of chronic diseases have reached epidemic proportions during the last decades and are not expected to decrease or diminish. In 2012, 38 million people died as a result of a non-communicable disease, of which 82% were due to cardiovascular diseases, diabetes, cancer and chronic respiratory diseases [<xref ref-type="bibr" rid="CR1">1</xref>]. This number is projected to increase to 52 million deaths by 2030 [<xref ref-type="bibr" rid="CR2">2</xref>]. Of particular concern is the fact that over 40% of all NCD deaths occurred before the age of 70 in 2012 [<xref ref-type="bibr" rid="CR1">1</xref>]. As a result of these developments, we must expect an increasing economic burden and reduction of quality of life in many societies, among both affected people and their social environment.</p><p id="Par12">Most, if not all, common chronic diseases develop over a lifetime as a result of interplay between genetic predisposition and the accumulation of lifetime exposures to environmental and behavioural factors. According to the World Health Organization (WHO), unhealthy diet, physical inactivity, tobacco use and harmful alcohol consumption are among the most important modifiable causes of chronic disease worldwide [<xref ref-type="bibr" rid="CR3">3</xref>]. For example, harmful alcohol use and tobacco use account for 12% of all deaths worldwide, and an additional 19% is accounted for by unhealthy diet and physical inactivity [<xref ref-type="bibr" rid="CR3">3</xref>]. As these are all modifiable, great potential exists for prevention or delay of chronic diseases, resulting in a renewed necessity for and interest in disease prediction and prevention [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par13">The fact that most chronic diseases seem to be preventable and the neoliberal political climate in many countries have contributed to the rise of personal responsibility for health [<xref ref-type="bibr" rid="CR5">5</xref>]. Individuals are more and more expected to strive to obtain and maintain their best possible health. In order to do so, they need to be optimally informed and make their own risk-benefit analyses. This has led to an exponential growth in services aiming at assisting in informing and assisting individuals to make informed decisions. Another such approach is through genetic testing [<xref ref-type="bibr" rid="CR6">6</xref>]. Although one has no control over their genetic make-up, knowledge of genetic predispositions could provide the opportunity for personalised prevention strategies and may serve in health-related decision-making [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>].</p><p id="Par14">Personal genomic testing (PGT) uses genetic variations in individuals to estimate personal disease risks and sometimes several other genetically determined phenotypes such as food intolerances or drug metabolism [<xref ref-type="bibr" rid="CR9">9</xref>]. PGT has become popular and accessible as a result of rapid advances in the field of DNA analysis techniques. This has made genome analysis possible at relatively low costs, with PGT companies like 23andMe dropping their price from US$999 in 2007 to US$199 in 2017 ([<xref ref-type="bibr" rid="CR10">10</xref>], <ext-link ext-link-type="uri" xlink:href="https://www.23andme.com/">https://www.23andme.com/</ext-link>). These services are mostly offered to the general population direct-to-consumer (DTC), meaning without interference of a physician. PGT may help individuals change their behaviour towards more health-promoting lifestyle through identification of an increased disease risk [<xref ref-type="bibr" rid="CR11">11</xref>]. An important assumption of the success of this strategy is that the identification of increased disease risk could directly influence risk reduction behaviours [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. However, research has shown that this assumption mostly does not apply in all populations or that the effects are minor in general populations [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par15">Limitations of this idea that PGT may facilitate behaviour change are that, firstly, probability and genetic data are difficult to comprehend without counselling [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>] and understanding is strongly influenced by several factors such as the format of delivery [<xref ref-type="bibr" rid="CR17">17</xref>]. Secondly, disease risks are not solely determined by either lifestyle or genetic factors, but both [<xref ref-type="bibr" rid="CR18">18</xref>]. Thirdly, disease risk information alone may not be motivating enough for individuals to change behaviour and therefore additional lifestyle intervention and motivational counselling may be necessary to help individuals change and maintain behaviour [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par16">To address these shortcomings, a new disease risk information service has been developed: <italic>Health Potential&#x000ae;</italic>. This service estimates a personal disease risk of a carefully selected list of preventable common chronic diseases that have both a genetic and a lifestyle component of development. The results are delivered face-to-face by a certified lifestyle counsellor, simultaneously stimulating initial steps towards behaviour change. Because previous research has shown that not all health care professionals feel confident in interpreting and communicating DTC-GT results to their patients or clients [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>], all Health Potential&#x000ae; counsellors are trained to ensure confidence and skill.</p><p id="Par17">The effect of this new personalised service will be researched in two integrated studies, one observational study and one intervention trial, comparing the service to a general health check only. The primary aim of the study is to study the effect of the Health Potential&#x000ae; advice on change in lifestyle behaviour in distinguishable customer populations. The secondary aims are (1) to study the effect of the Health Potential&#x000ae; service on determinants of behaviour change, (2) to study the effect of additional lifestyle counselling on behaviour change and determinants thereof, and (3) to study the characteristics of the Health Potential&#x000ae; customer.</p></sec><sec id="Sec2"><title>Methods/design</title><sec id="Sec3"><title>Study design</title><p id="Par18">This study consists of two integrated trials. The first trial is a non-randomised two-armed controlled pre-test/post-test superiority trial (part A). Of one of those arms, participants can enter the second trial, which is a randomised controlled pre-test/post-test superiority trial (part B), on the condition that they consent to participate. In order to obtain sufficient participants for part B, participants in part A will be distributed in a 1.5:1 ratio. Participants will be randomised at a 1:1 ratio in part B. This results in three study arms (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). However, due to eligible participants of part A potentially not consenting to participation in part B, study arm 2 can again be considered as two study arms: participants in arm 2a have consented to participate in part B whereas participants in 2b have not (see Fig. <xref rid="Fig1" ref-type="fig">1</xref> for a visualisation).<fig id="Fig1"><label>Fig. 1</label><caption><p>Conceptual framework</p></caption><graphic xlink:href="13063_2018_2630_Fig1_HTML" id="MO1"/></fig></p><sec id="Sec4"><title>Rationale for the study design</title><p id="Par19">The study is designed in a way to reflect the &#x02018;real world&#x02019; situation in which the participants are not randomised for part A and all participants pay a (reduced) fee for the services. The reason behind this approach is that we expect a certain level of &#x02018;pre-motivation&#x02019; and possibly other different personal characteristics (e.g. personality, socio-economic status, income, level of education, gender, age) among clients of the Health Potential&#x000ae; service, particularly when an additional &#x02018;barrier&#x02019; exists of a fee that has to be paid for the service.</p><p id="Par20">Due to the nature and cost of the products, and consistent with Rogers&#x02019; theory of early adopters [<xref ref-type="bibr" rid="CR21">21</xref>], the study population is likely to consist of (apparently) healthy individuals aged 18 and over, expected to have higher social status, higher financial resources, and higher education, and who are relatively health conscious.</p></sec></sec><sec id="Sec5"><title>Study setting</title><p id="Par21">Part A of the study takes place through online questionnaires, which participants can fill out at home. The additional lifestyle counselling will be offered through certified counsellors located in South-Limburg, The Netherlands.</p></sec><sec id="Sec6"><title>Participants and recruitment</title><p id="Par22">Participants for part A of the study will be recruited from the regular customers at local prevention clinics who have purchased one of the following products:<list list-type="bullet"><list-item><p id="Par23">Product 1: <italic>personalised health check</italic> (PHC). The PHC consists of the Health Potential&#x000ae; service (future health) and a general health check of the customer&#x02019;s current health.</p></list-item><list-item><p id="Par24">Product 2: a general health check of current health only (GHC).</p></list-item></list></p><p id="Par25">Potential participants will be informed of the study by the local responsible investigator of each clinic. Eligible participants for part A are apparently healthy individuals aged 18 and over, with a Dutch language level similar to language proficiency level B2, not currently following any prescribed dietary or other guidelines, not pregnant or trying to become pregnant, authorised to make autonomous decisions, able to independently visit the counselling clinic, and have Internet access and an email address. Participants who purchased product 1 are eligible to take part in part B of the study. Enrolment will be open for 1&#x000a0;year.</p></sec><sec id="Sec7"><title>Sample size and power calculation</title><p id="Par26">The sample size calculation is based on the proportion of participants who have changed their behaviour (being in the action/maintenance stage of behaviour change; see &#x02018;<xref rid="Sec10" ref-type="sec">Study parameters</xref>&#x02019;) for at least three of the received advices at follow-up in the overall analysis. The type I error rate was set at 0.05 and an additional 20% was added to compensate for loss to follow-up in part A.</p><p id="Par27"><italic>Part A</italic>: The smallest difference is expected between arms 2 and 3. It is estimated that with (291&#x02009;+&#x02009;20%=) 350 participants in each arm, part A has a power of 80% to detect a proportion of 0.3 in arm 2 versus a proportion of 0.2 in arm 3.</p><p id="Par28"><italic>Part B</italic>: Study arm 1 will be compared to arm 2a. It is then estimated that with (160&#x02009;+&#x02009;20%=) 192 participants in each arm, part B has a power of 80% to detect a proportion of 0.45 in arm 1 versus a proportion of 0.3 in arm 2a. As in part A 548 participants will be included in the PHC condition, this will give a margin of (548&#x02009;&#x02212;&#x02009;384=) 164 for participants not consenting to participate in part B. Together this results in a total number of participants of (192&#x02009;+&#x02009;350&#x02009;+&#x02009;350=) 892.</p></sec><sec id="Sec8"><title>Blinding, randomisation and treatment allocation</title><p id="Par29">Participants who purchased the PHC and who consented to participate in part B will be electronically randomised to receive the additional lifestyle counselling. Randomisation will be stratified by local clinic, and block randomisation will be used with block sizes of 4 within each stratum. The health coach will subsequently implement the appropriate intervention.</p><p id="Par30">Although blinding is not possible for the participants and the health counsellors delivering the intervention, the data analyses will be performed in a blinded format through preparation of the dataset by an independent researcher.</p></sec><sec id="Sec9"><title>Investigational behavioural intervention</title><p id="Par31">Part A does not contain an intervention. In part B, the participant receives additional lifestyle counselling. The lifestyle counselling consists of four additional personal face-to-face sessions with a purpose-trained lifestyle counsellor. The counselling follows four phases matching four core questions [<xref ref-type="bibr" rid="CR22">22</xref>] and is delivered using principles of motivational interviewing [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]:<list list-type="bullet"><list-item><p id="Par32">Counselling phase 1: &#x0201c;Am I at an increased risk because of my lifestyle?&#x0201d;</p></list-item><list-item><p id="Par33">Counselling phase 2: &#x0201c;Which choices are suitable for me?&#x0201d;</p></list-item><list-item><p id="Par34">Counselling phase 3: &#x0201c;How do I translate my choices to behaviour?&#x0201d;</p></list-item><list-item><p id="Par35">Counselling phase 4: &#x0201c;How can I maintain my change in behaviour?&#x0201d;</p></list-item></list></p><p id="Par36">All lifestyle counselling sessions are done by the same certified lifestyle counsellors for one participant. The sessions take place at <italic>t</italic>&#x000a0;=&#x02009;0&#x000a0;week, <italic>t</italic>&#x000a0;=&#x02009;1&#x000a0;week, <italic>t</italic>&#x000a0;=&#x02009;4&#x000a0;weeks and <italic>t</italic>&#x000a0;=&#x02009;12&#x000a0;weeks (see Fig. <xref rid="Fig1" ref-type="fig">1</xref>, sessions 2&#x02013;5) and will last approximately 45&#x02013;60&#x000a0;min per session.</p></sec><sec id="Sec10"><title>Study parameters</title><p id="Par37">To study the effect of Health Potential&#x000ae; on behaviour change, a conceptual framework has been developed (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>), based on a previously proposed framework for PGT by Bloss et al. [<xref ref-type="bibr" rid="CR8">8</xref>] and the I-change model [<xref ref-type="bibr" rid="CR25">25</xref>]. The framework consists of two steps that are relevant for eventual behaviour change: (1) purchasing Health Potential&#x000ae; and (2) behaviour change as a result of Health Potential&#x000ae;. Determinants included in both steps are based on the literature on PGT [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR26">26</xref>&#x02013;<xref ref-type="bibr" rid="CR36">36</xref>] and the I-change model [<xref ref-type="bibr" rid="CR37">37</xref>].<fig id="Fig2"><label>Fig. 2</label><caption><p>Flow chart of the study</p></caption><graphic xlink:href="13063_2018_2630_Fig2_HTML" id="MO2"/></fig></p><p id="Par38">All parameters (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>) are measured using online questionnaires, as part of part A of the study, and are saved in a coded format. Measurements take place at <italic>t</italic>&#x000a0;=&#x02009;&#x02212;6&#x000a0;weeks (baseline), <italic>t</italic>&#x000a0;=&#x02009;0&#x000a0;week, <italic>t</italic>&#x000a0;=&#x02009;1&#x000a0;week, <italic>t</italic>&#x000a0;=&#x02009;4&#x000a0;weeks, <italic>t</italic>&#x000a0;=&#x02009;12&#x000a0;weeks, <italic>t</italic>&#x000a0;=&#x02009;6&#x000a0;months and <italic>t</italic>&#x000a0;=&#x02009;1&#x000a0;year (Figs.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref> and <xref rid="Fig4" ref-type="fig">4</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Outcome parameters and other parameters</p></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="2">Outcome parameters</td></tr><tr><td>&#x02003;Behaviour change (stage of change)</td><td>Questionnaire containing 1 question per advice received to determine the current stage of change (transtheoretical model (Fig. <xref rid="Fig4" ref-type="fig">4</xref>) [<xref ref-type="bibr" rid="CR43">43</xref>&#x02013;<xref ref-type="bibr" rid="CR45">45</xref>]).</td></tr><tr><td>&#x02003;Behaviour change (verification)</td><td>Physical activity: the validated Dutch version of the International Physical Activity Questionnaire (IPAQ) [<xref ref-type="bibr" rid="CR46">46</xref>].<break/>Smoking: questions on current smoking behaviour and quantity of smoking.<break/>Dietary and alcohol intake: questions on regular intake of all food groups and alcoholic consumptions, for which advice is received by the participant.<break/>Body weight and waist circumference: measured at home by the participant, following detailed instructions and using the same weighing scale each time.</td></tr><tr><td>&#x02003;Motivational regulation</td><td>Validated Treatment Self-Regulation Questionnaire (TSRQ) [<xref ref-type="bibr" rid="CR47">47</xref>], translated into Dutch. This questionnaire has been modified to ask motivational regulation with regard to the &#x02018;advice given&#x02019; and &#x02018;healthy lifestyle&#x02019;.</td></tr><tr><td>&#x02003;Attitude</td><td>Questionnaire consisting of 7 Likert scale items on outcome expectations, 16 Likert scale items on the reasons for (not) undergoing testing by Health Potential&#x000ae;, 50 Likert scale items on the attitude towards five primary lifestyle behaviours, 1 Likert scale item on the importance of preventing disease, and 6 items on the evaluation of the Health Potential&#x000ae; report.</td></tr><tr><td>&#x02003;Behaviour-specific self-efficacy</td><td>Questionnaire which was developed using the &#x02018;Guide for constructing self-efficacy scales&#x02019; by Bandura [<xref ref-type="bibr" rid="CR48">48</xref>]. It includes one self-efficacy question for each advice given in which the participant indicates on a scale of 0&#x02013;100% how sure they are of their ability to follow the advice.</td></tr><tr><td>&#x02003;Risk perception</td><td>Likert scale questions on the perceived probability of getting and severity [<xref ref-type="bibr" rid="CR37">37</xref>] of each of the diseases included in the standard Health Potential&#x000ae; service.</td></tr><tr><td>&#x02003;Perceived stress</td><td>Dutch translation of the validated 14-item Perceived Stress Scale (PSS) [<xref ref-type="bibr" rid="CR49">49</xref>].</td></tr><tr><td>&#x02003;Discussion of test results with health professionals and/or family and friends</td><td>Multiple-answer question in which the participant can indicate with whom the results were discussed.</td></tr><tr><td>&#x02003;Test-related distress (arms 1 and 2 only)</td><td>Dutch translation [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>] of the validated Impact of Event Scale (IES), which has been used previously to study test-related distress after genetic testing for common disease risk [<xref ref-type="bibr" rid="CR39">39</xref>].</td></tr><tr><td colspan="2">Other study parameters</td></tr><tr><td>&#x02003;Self-reported health status</td><td>Dutch translation of the validated RAND 36-Item Short Form Health Survey, V2 (SF-36 V2) [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>].</td></tr><tr><td>&#x02003;Health locus of control</td><td>Dutch translation of the validated Multidimensional Health Locus of Control (MHLC) Scale [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>].</td></tr><tr><td>&#x02003;Comprehension of risk estimates (arms 1 and 2 only)</td><td>Questions based on the questions used by Kaufman et al. [<xref ref-type="bibr" rid="CR56">56</xref>].</td></tr><tr><td>&#x02003;Genetic knowledge (arms 1 and 2 only)</td><td>Dutch translation of the questions as used by Carere et al. [<xref ref-type="bibr" rid="CR57">57</xref>].</td></tr><tr><td>&#x02003;Cue to action</td><td>Two Likert scale questions on whether the participant felt the Health Potential&#x000ae; report and the general health check were a cue to action.</td></tr><tr><td>&#x02003;Personal and family history of tested diseases</td><td>Questionnaire asking about personal and family history.</td></tr><tr><td>&#x02003;General self-efficacy</td><td>Validated Dutch General Self-Efficacy Scale (DGSES) [<xref ref-type="bibr" rid="CR58">58</xref>].</td></tr><tr><td>&#x02003;Social modelling, social support</td><td>One Likert scale question per advice received.</td></tr><tr><td>&#x02003;Social support</td><td>One Likert scale question per lifestyle domain (diet, alcohol, physical activity, smoking, body weight).</td></tr><tr><td>&#x02003;Pro-active coping skills</td><td>Validated Utrechtse Pro-actieve Coping Competenties (UPCC) questionnaire [<xref ref-type="bibr" rid="CR59">59</xref>].</td></tr><tr><td>&#x02003;Vitality</td><td>Validated Vita-16 [<xref ref-type="bibr" rid="CR60">60</xref>].</td></tr><tr><td>&#x02003;Previous participation in genetic testing</td><td>Two yes/no questions.</td></tr><tr><td>&#x02003;Temporal discounting</td><td>Validated 10-item Delaying Gratification Inventory short form, translated into Dutch (DGI-10) [<xref ref-type="bibr" rid="CR61">61</xref>].</td></tr><tr><td>&#x02003;Personality</td><td>Validated Dutch IPIP-50 [<xref ref-type="bibr" rid="CR62">62</xref>].</td></tr></tbody></table></table-wrap><fig id="Fig3"><label>Fig. 3</label><caption><p>Schedule of enrolment, interventions and assessment</p></caption><graphic xlink:href="13063_2018_2630_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>Transtheoretical model [<xref ref-type="bibr" rid="CR43">43</xref>&#x02013;<xref ref-type="bibr" rid="CR45">45</xref>]</p></caption><graphic xlink:href="13063_2018_2630_Fig4_HTML" id="MO4"/></fig></p></sec><sec id="Sec11"><title>Statistical analysis</title><p id="Par39">Where appropriate, the analyses will be performed according to an intention-to-treat (ITT) approach (part B only) and per-protocol approach. Data will be analysed using STATA (StataCorp. Stata Statistical Software, College Station, TX: StataCorp LP). Statistical significance is assumed at a <italic>p</italic> value of 0.05, and no correction for multiple testing will be applied.</p></sec><sec id="Sec12"><title>Ethical considerations</title><p id="Par40">Due to the nature of the researched population and the very limited risks associated with the study, no data safety monitoring board or safety committee is deemed necessary. No interim analyses will be performed.</p><p id="Par41">The full protocols, for both parts A and B, can be found on <ext-link ext-link-type="uri" xlink:href="https://dataverse.nl/dataset.xhtml?persistentId=hdl:10411/XKOM8H">https://dataverse.nl/dataset.xhtml?persistentId=hdl:10411/XKOM8H</ext-link> identifier 10411/XKOM8H (see also Additional file <xref rid="MOESM1" ref-type="media">1</xref>).</p></sec></sec><sec id="Sec13"><title>Discussion</title><p id="Par42">To our best knowledge, this is the first trial investigating such a wide range of determinants with regard to the effect of a disease prevention service based on both genetic and lifestyle components of disease risk. The study will contribute to the debate on whether genetic prevention services can be effective in improving lifestyle behaviour in certain customer groups and will help identify actionable determinants that contribute to an increased effect. Health Potential&#x000ae; will support the individual in making informed decisions about their health and lifestyle, which will become increasingly important in the current paradigm of personal responsibility for one&#x02019;s health.</p><p id="Par43">The study has several strengths and risks. Firstly, the pragmatic approach of the study will give a good indication of the effect in a real-life situation after implementation, resulting in a small theory-practice gap. However, on the one hand, it may also result in greater heterogeneity and thereby a dilution of the effect. On the other hand, the expected population of mostly early adopters might again reduce heterogeneity. Secondly, due to this pragmatic approach and the relatively high cost of genetic testing, the study population can be expected to be a selective group of higher educated individuals with a relatively high income. As health and lifestyle are associated with socio-economic position, services like Health Potential&#x000ae; may contribute to increasing health inequalities when the test is purchased personally. In the future, employers or municipalities may subsidise such tests for their employees or certain groups of inhabitants, which could diminish this effect. Finally, the outcomes include a wide range of actionable determinants of behaviour change, which will allow us to investigate through which determinants the effect on behaviour change is achieved. Knowing these explanatory variables may then inform us about the determinants that need to be addressed further in order to achieve a greater effect on behaviour change, direct recruitment strategies, and guide further development of genetic testing services. In addition, identification of specific groups of customers in which an effect is or is not seen will further help to tailor strategies.</p><p id="Par44">PGT services, such as Health Potential&#x000ae;, also carry some risks and benefits for the consumer. Firstly, because of the high psychological impact of genetic testing for diseases with a strong genotype-phenotype interaction, it is under debate whether genetic testing for common disease risk also leads to too high levels of distress among participants. However, recent studies have suggested that the level of distress is minimal [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. The close contact between client and coach is hypothesised to further reduce any worry or distress and in case any serious distress arises, this can be recognised at an early stage and appropriate action can be taken. Whether this holds true will also be examined in this study. Secondly, a serious risk of PGT services is misinterpretation of test results by consumers [<xref ref-type="bibr" rid="CR16">16</xref>]. Consequences of misinterpretation may be undermined motivation (e.g. interpreting a reduced risk as definitely not getting the disease), unnecessary worry and distress, and a burden on the health care system through requesting unnecessary medical tests and asking for help from health care professionals to interpret the results [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. To address the issue, the Health Potential&#x000ae; report has been based on literature on communication of disease risks [<xref ref-type="bibr" rid="CR41">41</xref>] and the results are explained to the client face-to-face by a certified Health Potential&#x000ae; coach. Finally, Health Potential&#x000ae; has a strong connection with her end users, including both coaches and clients. In the development of the supporting software and the communication of results, end users have been involved. This involvement is crucial for the acceptance and therefore viability of a service [<xref ref-type="bibr" rid="CR42">42</xref>].</p><p id="Par45">This research can provide valuable insights into the effectiveness of PGT services. These findings can be used in the development and improvement of lifestyle interventions enriched with modern genetic advancements.</p></sec><sec id="Sec14"><title>Trial status</title><p id="Par46">The trial is currently in preparation.</p></sec><sec sec-type="supplementary-material"><title>Additional file</title><sec id="Sec15"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13063_2018_2630_MOESM1_ESM.doc"><label>Additional file 1:</label><caption><p>SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documents. (DOC 123&#x000a0;kb)</p></caption></media></supplementary-material>
</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>DTC</term><def><p id="Par5">Direct-to-consumer</p></def></def-item><def-item><term>GHC</term><def><p id="Par6">General health check</p></def></def-item><def-item><term>METC </term><def><p id="Par7">Medisch Ethische Toetsings Commissie (Medical Research Ethics Committee (MREC))</p></def></def-item><def-item><term>PGT</term><def><p id="Par8">Personal genomic testing</p></def></def-item><def-item><term>PHC</term><def><p id="Par9">Personal health check</p></def></def-item><def-item><term>WHO</term><def><p id="Par10">World Health Organization</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (10.1186/s13063-018-2630-7) contains supplementary material, which is available to authorized users.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors wish to thank Stofberg Group for their assistance in planning the logistical aspects of the study and Operis for their support in the certification course of the Health Potential&#x000ae; counsellors.</p><sec id="FPar1"><title>Funding</title><p id="Par47">This project was funded by the Maastricht University Interfaculty Programme &#x02018;Eatwell&#x02019;. The funder had no influence in the development of the protocol.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par48">Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>All authors (KS, AW, AS and MZ) contributed substantially to the conception and design of the study and ethical submissions. KS drafted the manuscript, which was critically revised by AW, MZ and AS. AW, AS and MZ obtained funding. All authors read and approved the final manuscript and have given approval for the publication of this paper.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p id="Par49">The protocol has been approved by the METC AzM/UM (numbers 16-4-077 and 163014) and is registered on <ext-link ext-link-type="uri" xlink:href="http://www.trialregister.nl">www.trialregister.nl</ext-link> on 24 February 2017 with registration numbers NTR6289 and NTR6288. Informed consent will be obtained from each participant for both part A and part B separately.</p></sec><sec id="FPar4"><title>Competing interests</title><p id="Par50">Health Potential may become a spin-off service from Maastricht University led by Prof. Maurice Zeegers.</p></sec><sec id="FPar5"><title>Publisher&#x02019;s Note</title><p id="Par51">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Alwan</surname><given-names>A</given-names></name></person-group><source>Global status report on noncommunicable diseases 2010</source><year>2011</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">Projections of mortality and causes of death, 2015 and 2030. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/healthinfo/global_burden_disease/projections/en/">http://www.who.int/healthinfo/global_burden_disease/projections/en/</ext-link>. Accessed 5 Jan 2017.</mixed-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Global health risks: mortality and burden of disease attributable to selected major risks</source><year>2009</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>AR</given-names></name></person-group><article-title>Modern medicine: towards prevention, cure, well-being and longevity</article-title><source>Mens Sana Monographs</source><year>2009</year><volume>8</volume><issue>1</issue><fpage>11</fpage></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Resnik</surname><given-names>DB</given-names></name></person-group><article-title>Responsibility for health: personal, social, and environmental</article-title><source>J Med Ethics</source><year>2007</year><volume>33</volume><issue>8</issue><fpage>444</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1136/jme.2006.017574</pub-id><pub-id pub-id-type="pmid">17664299</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Resnik</surname><given-names>DB</given-names></name></person-group><article-title>Genetics and personal responsibility for health</article-title><source>New Genet Soc</source><year>2014</year><volume>33</volume><issue>2</issue><fpage>113</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1080/14636778.2014.905195</pub-id><pub-id pub-id-type="pmid">25598702</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">Stewart K, Schreurs M, Wesselius A, Schols A, Zeegers M. Behavioural changes and psychological responses after receiving direct-to-consumer genetic test results: a systematic review and meta-analysis. J Comm Genet. 2017. (in press)</mixed-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloss</surname><given-names>CS</given-names></name><name><surname>Madlensky</surname><given-names>L</given-names></name><name><surname>Schork</surname><given-names>NJ</given-names></name><name><surname>Topol</surname><given-names>EJ</given-names></name></person-group><article-title>Genomic information as a behavioral health intervention: can it work?</article-title><source>Per Med</source><year>2011</year><volume>8</volume><issue>6</issue><fpage>659</fpage><lpage>667</lpage><pub-id pub-id-type="doi">10.2217/pme.11.73</pub-id><pub-id pub-id-type="pmid">22199991</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gollust</surname><given-names>SE</given-names></name><name><surname>Wilfond</surname><given-names>BS</given-names></name><name><surname>Hull</surname><given-names>SC</given-names></name></person-group><article-title>Direct-to-consumer sales of genetic services on the Internet</article-title><source>Genet Med</source><year>2003</year><volume>5</volume><issue>4</issue><fpage>332</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1097/01.GIM.0000076972.83711.48</pub-id><pub-id pub-id-type="pmid">12865763</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Another $50M richer, 23andMe drops its price to $99 permanently. But will the average dude buy in? <ext-link ext-link-type="uri" xlink:href="https://techcrunch.com/2012/12/11/23andnotme/">https://techcrunch.com/2012/12/11/23andnotme/</ext-link>. Accessed 23 Mar 2017.</mixed-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Offit</surname><given-names>K</given-names></name></person-group><article-title>Personalized medicine: new genomics, old lessons</article-title><source>Hum Genet</source><year>2011</year><volume>130</volume><issue>1</issue><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1007/s00439-011-1028-3</pub-id><pub-id pub-id-type="pmid">21706342</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henrikson</surname><given-names>NB</given-names></name><name><surname>Bowen</surname><given-names>D</given-names></name><name><surname>Burke</surname><given-names>W</given-names></name></person-group><article-title>Does genomic risk information motivate people to change their behavior</article-title><source>Genome Med</source><year>2009</year><volume>1</volume><issue>4</issue><fpage>37</fpage><pub-id pub-id-type="doi">10.1186/gm37</pub-id><pub-id pub-id-type="pmid">19341508</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leventhal</surname><given-names>H</given-names></name><name><surname>Benyamini</surname><given-names>Y</given-names></name><name><surname>Brownlee</surname><given-names>S</given-names></name><name><surname>Diefenbach</surname><given-names>M</given-names></name><name><surname>Leventhal</surname><given-names>EA</given-names></name><name><surname>Patrick-Miller</surname><given-names>L</given-names></name><name><surname>Robitaille</surname><given-names>C</given-names></name></person-group><article-title>Illness representations: theoretical foundations</article-title><source>Percept Health Illn</source><year>1997</year><volume>2</volume><fpage>19</fpage><lpage>46</lpage></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>JS</given-names></name><name><surname>Ostergren</surname><given-names>J</given-names></name></person-group><article-title>Direct-to-consumer genetic testing and personal genomics services: a review of recent empirical studies</article-title><source>Curr Genet Med Rep</source><year>2013</year><volume>1</volume><issue>3</issue><fpage>182</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1007/s40142-013-0018-2</pub-id><pub-id pub-id-type="pmid">24058877</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanie</surname><given-names>AD</given-names></name><name><surname>Jayaratne</surname><given-names>TE</given-names></name><name><surname>Sheldon</surname><given-names>JP</given-names></name><name><surname>Kardia</surname><given-names>SL</given-names></name><name><surname>Anderson</surname><given-names>ES</given-names></name><name><surname>Feldbaum</surname><given-names>M</given-names></name><name><surname>Petty</surname><given-names>EM</given-names></name></person-group><article-title>Exploring the public understanding of basic genetic concepts</article-title><source>J Genet Couns</source><year>2004</year><volume>13</volume><issue>4</issue><fpage>305</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1023/B:JOGC.0000035524.66944.6d</pub-id><pub-id pub-id-type="pmid">19736696</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGrath</surname><given-names>SP</given-names></name><name><surname>Coleman</surname><given-names>J</given-names></name><name><surname>Najjar</surname><given-names>L</given-names></name><name><surname>Fruhling</surname><given-names>A</given-names></name><name><surname>Bastola</surname><given-names>DR</given-names></name></person-group><article-title>Comprehension and data-sharing behavior of direct-to-consumer genetic test customers</article-title><source>Public Health Genomics</source><year>2016</year><volume>19</volume><issue>2</issue><fpage>116</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1159/000444477</pub-id><pub-id pub-id-type="pmid">26950077</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fausset</surname><given-names>CB</given-names></name></person-group><source>Comprehension of health risk probabilities: the roles of age, numeracy, format, and mental representation</source><year>2012</year></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Zalabani</surname><given-names>AH</given-names></name><name><surname>Stewart</surname><given-names>KFJ</given-names></name><name><surname>Wesselius</surname><given-names>A</given-names></name><name><surname>Schols</surname><given-names>MWJ</given-names></name><name><surname>Zeegers</surname><given-names>MP</given-names></name></person-group><article-title>Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses</article-title><source>Eur J Epidemiol</source><year>2016</year><volume>31</volume><issue>9</issue><fpage>811</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1007/s10654-016-0138-6</pub-id><pub-id pub-id-type="pmid">27000312</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>KD</given-names></name><name><surname>Vassy</surname><given-names>JL</given-names></name><name><surname>Jamal</surname><given-names>L</given-names></name><name><surname>Lehmann</surname><given-names>LS</given-names></name><name><surname>Slashinski</surname><given-names>MJ</given-names></name><name><surname>Perry</surname><given-names>DL</given-names></name><name><surname>Robinson</surname><given-names>JO</given-names></name><name><surname>Blumenthal-Barby</surname><given-names>J</given-names></name><name><surname>Feuerman</surname><given-names>LZ</given-names></name><name><surname>Murray</surname><given-names>MF</given-names></name><etal/></person-group><article-title>Are physicians prepared for whole genome sequencing? A qualitative analysis</article-title><source>Clin Genet</source><year>2016</year><volume>89</volume><issue>2</issue><fpage>228</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1111/cge.12626</pub-id><pub-id pub-id-type="pmid">26080898</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldsmith</surname><given-names>L</given-names></name><name><surname>Jackson</surname><given-names>L</given-names></name><name><surname>O'Connor</surname><given-names>A</given-names></name><name><surname>Skirton</surname><given-names>H</given-names></name></person-group><article-title>Direct-to-consumer genomic testing: systematic review of the literature on user perspectives</article-title><source>Eur J Hum Genet</source><year>2012</year><volume>20</volume><issue>8</issue><fpage>811</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1038/ejhg.2012.18</pub-id><pub-id pub-id-type="pmid">22333900</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>EM</given-names></name></person-group><source>Diffusion of innovations</source><year>2003</year><edition>5</edition><publisher-loc>New York</publisher-loc><publisher-name>Simon and Schuster</publisher-name></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lak</surname><given-names>M</given-names></name><name><surname>Bijma</surname><given-names>M</given-names></name></person-group><source>Leefstijlcoaching: kernvragen bij gedragsverandering</source><year>2012</year><publisher-loc>Houten</publisher-loc><publisher-name>Bohn Stafleu van Loghum</publisher-name></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>WR</given-names></name></person-group><article-title>Motivational interviewing with problem drinkers</article-title><source>Behav Psychother</source><year>1983</year><volume>11</volume><issue>02</issue><fpage>147</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1017/S0141347300006583</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubak</surname><given-names>S</given-names></name><name><surname>Sandb&#x000e6;k</surname><given-names>A</given-names></name><name><surname>Lauritzen</surname><given-names>T</given-names></name><name><surname>Christensen</surname><given-names>B</given-names></name></person-group><article-title>Motivational interviewing: a systematic review and meta-analysis</article-title><source>Br J Gen Pract</source><year>2005</year><volume>55</volume><issue>513</issue><fpage>305</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">15826439</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Vries</surname><given-names>H</given-names></name><name><surname>Mesters</surname><given-names>I</given-names></name><name><surname>van't Riet</surname><given-names>J</given-names></name><name><surname>Willems</surname><given-names>K</given-names></name><name><surname>Reubsaet</surname><given-names>A</given-names></name></person-group><article-title>Motives of Belgian adolescents for using sunscreen: the role of action plans</article-title><source>Cancer Epidemiol Biomark Prev</source><year>2006</year><volume>15</volume><issue>7</issue><fpage>1360</fpage><lpage>1366</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-05-0877</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vayena</surname><given-names>E</given-names></name><name><surname>Ineichen</surname><given-names>C</given-names></name><name><surname>Stoupka</surname><given-names>E</given-names></name><name><surname>Hafen</surname><given-names>E</given-names></name></person-group><article-title>Playing a part in research university students&#x02019; attitudes to direct-to-consumer genomics</article-title><source>Public Health Genomics</source><year>2014</year><volume>17</volume><issue>3</issue><fpage>158</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1159/000360257</pub-id><pub-id pub-id-type="pmid">24777115</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweeny</surname><given-names>K</given-names></name><name><surname>Legg</surname><given-names>AM</given-names></name></person-group><article-title>Predictors of interest in direct-to-consumer genetic testing</article-title><source>Psychol Health</source><year>2011</year><volume>26</volume><issue>10</issue><fpage>1259</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1080/08870446.2010.514607</pub-id><pub-id pub-id-type="pmid">21500101</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Cherkas LF, Harris JM, Levinson E, Spector TD, Prainsack B. A survey of UK public interest in Internet-based personal genome testing. PLoS One. 2010;5(10):e13473.</mixed-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Howard</surname><given-names>HC</given-names></name><name><surname>Borry</surname><given-names>P</given-names></name></person-group><article-title>Users&#x02019; motivations to purchase direct-to-consumer genome-wide testing: an exploratory study of personal stories</article-title><source>J Comm Genet</source><year>2011</year><volume>2</volume><issue>3</issue><fpage>135</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1007/s12687-011-0048-y</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vayena</surname><given-names>E</given-names></name><name><surname>Gourna</surname><given-names>E</given-names></name><name><surname>Streuli</surname><given-names>J</given-names></name><name><surname>Hafen</surname><given-names>E</given-names></name><name><surname>Prainsack</surname><given-names>B</given-names></name></person-group><article-title>Experiences of early users of direct-to-consumer genomics in Switzerland: an exploratory study</article-title><source>Public Health Genomics</source><year>2012</year><volume>15</volume><issue>6</issue><fpage>352</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1159/000343792</pub-id><pub-id pub-id-type="pmid">23154382</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGowan</surname><given-names>ML</given-names></name><name><surname>Fishman</surname><given-names>JR</given-names></name><name><surname>Lambrix</surname><given-names>MA</given-names></name></person-group><article-title>Personal genomics and individual identities: motivations and moral imperatives of early users</article-title><source>New Genet Soc</source><year>2010</year><volume>29</volume><issue>3</issue><fpage>261</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1080/14636778.2010.507485</pub-id><pub-id pub-id-type="pmid">21076647</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBride</surname><given-names>CM</given-names></name><name><surname>Alford</surname><given-names>SH</given-names></name><name><surname>Reid</surname><given-names>RJ</given-names></name><name><surname>Larson</surname><given-names>EB</given-names></name><name><surname>Baxevanis</surname><given-names>AD</given-names></name><name><surname>Brody</surname><given-names>LC</given-names></name></person-group><article-title>Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions</article-title><source>Genet Med</source><year>2009</year><volume>11</volume><issue>8</issue><fpage>582</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1097/GIM.0b013e3181b22c3a</pub-id><pub-id pub-id-type="pmid">19606049</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gollust</surname><given-names>SE</given-names></name><name><surname>Gordon</surname><given-names>ES</given-names></name><name><surname>Zayac</surname><given-names>C</given-names></name><name><surname>Griffin</surname><given-names>G</given-names></name><name><surname>Christman</surname><given-names>MF</given-names></name><name><surname>Pyeritz</surname><given-names>RE</given-names></name><name><surname>Wawak</surname><given-names>L</given-names></name><name><surname>Bernhardt</surname><given-names>BA</given-names></name></person-group><article-title>Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants</article-title><source>Public Health Genomics</source><year>2012</year><volume>15</volume><issue>1</issue><fpage>22</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1159/000327296</pub-id><pub-id pub-id-type="pmid">21654153</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mavroidopoulou</surname><given-names>V</given-names></name><name><surname>Xera</surname><given-names>E</given-names></name><name><surname>Mollaki</surname><given-names>V</given-names></name></person-group><article-title>Awareness, attitudes and perspectives of direct-to-consumer genetic testing in Greece: a survey of potential consumers</article-title><source>J Hum Genet</source><year>2015</year><volume>60</volume><issue>9</issue><fpage>515</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1038/jhg.2015.58</pub-id><pub-id pub-id-type="pmid">26040209</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGuire</surname><given-names>AL</given-names></name><name><surname>Diaz</surname><given-names>CM</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Hilsenbeck</surname><given-names>SG</given-names></name></person-group><article-title>Social networkers&#x02019; attitudes toward direct-to-consumer personal genome testing</article-title><source>Am J Bioeth</source><year>2009</year><volume>9</volume><issue>6&#x02013;7</issue><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1080/15265160902928209</pub-id><pub-id pub-id-type="pmid">19998099</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloss</surname><given-names>CS</given-names></name><name><surname>Ornowski</surname><given-names>L</given-names></name><name><surname>Silver</surname><given-names>E</given-names></name><name><surname>Cargill</surname><given-names>M</given-names></name><name><surname>Vanier</surname><given-names>V</given-names></name><name><surname>Schork</surname><given-names>NJ</given-names></name><name><surname>Topol</surname><given-names>EJ</given-names></name></person-group><article-title>Consumer perceptions of direct-to-consumer personalized genomic risk assessments</article-title><source>Genet Med</source><year>2010</year><volume>12</volume><issue>9</issue><fpage>556</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1097/GIM.0b013e3181eb51c6</pub-id><pub-id pub-id-type="pmid">20717041</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Vries</surname><given-names>H</given-names></name><name><surname>Mesters</surname><given-names>I</given-names></name><name><surname>Van de Steeg</surname><given-names>H</given-names></name><name><surname>Honing</surname><given-names>C</given-names></name></person-group><article-title>The general public&#x02019;s information needs and perceptions regarding hereditary cancer: an application of the Integrated Change Model</article-title><source>Patient Educ Couns</source><year>2005</year><volume>56</volume><issue>2</issue><fpage>154</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/j.pec.2004.01.002</pub-id><pub-id pub-id-type="pmid">15653244</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloss</surname><given-names>CS</given-names></name><name><surname>Schork</surname><given-names>NJ</given-names></name><name><surname>Topol</surname><given-names>EJ</given-names></name></person-group><article-title>Effect of direct-to-consumer genomewide profiling to assess disease risk</article-title><source>N Engl J Med</source><year>2011</year><volume>364</volume><issue>6</issue><fpage>524</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1011893</pub-id><pub-id pub-id-type="pmid">21226570</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="other">Bloss CS, Wineinger NE, Darst BF, Schork NJ, Topol EJ. Impact of direct-to-consumer genomic testing at long term follow-up. J Med Genet. 2013; 10.1136/jmedgenet-2012-101207.</mixed-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skirton</surname><given-names>H</given-names></name><name><surname>Jackson</surname><given-names>L</given-names></name><name><surname>Goldsmith</surname><given-names>L</given-names></name><name><surname>O'Connor</surname><given-names>A</given-names></name></person-group><article-title>Are health professionals ready for direct-to-consumer genetic and genomic testing?</article-title><source>Per Med</source><year>2013</year><volume>10</volume><issue>7</issue><fpage>673</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.2217/pme.13.71</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lautenbach</surname><given-names>DM</given-names></name><name><surname>Christensen</surname><given-names>KD</given-names></name><name><surname>Sparks</surname><given-names>JA</given-names></name><name><surname>Green</surname><given-names>RC</given-names></name></person-group><article-title>Communicating genetic risk information for common disorders in the era of genomic medicine</article-title><source>Annu Rev Genomics Hum Genet</source><year>2012</year><volume>14</volume><fpage>491</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1146/annurev-genom-092010-110722</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaspers</surname><given-names>MWM</given-names></name></person-group><article-title>A comparison of usability methods for testing interactive health technologies: methodological aspects and empirical evidence</article-title><source>Int J Med Inform</source><year>2009</year><volume>78</volume><issue>5</issue><fpage>340</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1016/j.ijmedinf.2008.10.002</pub-id><pub-id pub-id-type="pmid">19046928</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prochaska</surname><given-names>JO</given-names></name><name><surname>DiClemente</surname><given-names>CC</given-names></name><name><surname>Velicer</surname><given-names>WF</given-names></name><name><surname>Ginpil</surname><given-names>S</given-names></name><name><surname>Norcross</surname><given-names>JC</given-names></name></person-group><article-title>Predicting change in smoking status for self-changers</article-title><source>Addict Behav</source><year>1985</year><volume>10</volume><issue>4</issue><fpage>395</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/0306-4603(85)90036-X</pub-id><pub-id pub-id-type="pmid">4091072</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prochaska</surname><given-names>JO</given-names></name><name><surname>Goldstein</surname><given-names>MG</given-names></name></person-group><article-title>Process of smoking cessation. Implications for clinicians</article-title><source>Clin Chest Med</source><year>1991</year><volume>12</volume><issue>4</issue><fpage>727</fpage><lpage>735</lpage><pub-id pub-id-type="pmid">1747990</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prochaska</surname><given-names>JO</given-names></name><name><surname>Velicer</surname><given-names>WF</given-names></name></person-group><article-title>The transtheoretical model of health behavior change</article-title><source>Am J Health Promot</source><year>1997</year><volume>12</volume><issue>1</issue><fpage>38</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.4278/0890-1171-12.1.38</pub-id><pub-id pub-id-type="pmid">10170434</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname><given-names>CL</given-names></name><name><surname>Marshall</surname><given-names>AL</given-names></name><name><surname>Sjostrom</surname><given-names>M</given-names></name><name><surname>Bauman</surname><given-names>AE</given-names></name><name><surname>Booth</surname><given-names>ML</given-names></name><name><surname>Ainsworth</surname><given-names>BE</given-names></name><name><surname>Pratt</surname><given-names>M</given-names></name><name><surname>Ekelund</surname><given-names>U</given-names></name><name><surname>Yngve</surname><given-names>A</given-names></name><name><surname>Sallis</surname><given-names>JF</given-names></name><etal/></person-group><article-title>International physical activity questionnaire: 12-country reliability and validity</article-title><source>Med Sci Sports Exerc</source><year>2003</year><volume>35</volume><issue>8</issue><fpage>1381</fpage><lpage>1395</lpage><pub-id pub-id-type="doi">10.1249/01.MSS.0000078924.61453.FB</pub-id><pub-id pub-id-type="pmid">12900694</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>RM</given-names></name><name><surname>Connell</surname><given-names>JP</given-names></name></person-group><article-title>Perceived locus of causality and internalization: examining reasons for acting in two domains</article-title><source>J Pers Soc Psychol</source><year>1989</year><volume>57</volume><issue>5</issue><fpage>749</fpage><pub-id pub-id-type="doi">10.1037/0022-3514.57.5.749</pub-id><pub-id pub-id-type="pmid">2810024</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandura</surname><given-names>A</given-names></name></person-group><article-title>Guide for constructing self-efficacy scales</article-title><source>Self-efficacy Beliefs Adolesc</source><year>2006</year><volume>5</volume><fpage>307</fpage><lpage>337</lpage></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>S</given-names></name><name><surname>Kamarck</surname><given-names>T</given-names></name><name><surname>Mermelstein</surname><given-names>R</given-names></name></person-group><article-title>A global measure of perceived stress</article-title><source>J Health Soc Behav</source><year>1983</year><volume>24</volume><issue>4</issue><fpage>385</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.2307/2136404</pub-id><pub-id pub-id-type="pmid">6668417</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brom</surname><given-names>D</given-names></name><name><surname>Kleber</surname><given-names>RJ</given-names></name></person-group><article-title>De Schok Verwerkings Lijst [The Dutch version of the Impact of Event Scale]</article-title><source>Nederlands Tijdschrift voor de Psychologie</source><year>1985</year><volume>40</volume><fpage>164</fpage><lpage>168</lpage></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Ploeg</surname><given-names>E</given-names></name><name><surname>Mooren</surname><given-names>T</given-names></name><name><surname>Kleber</surname><given-names>RJ</given-names></name><name><surname>van der Velden</surname><given-names>PG</given-names></name><name><surname>Brom</surname><given-names>D</given-names></name></person-group><article-title>Construct validation of the Dutch version of the impact of event scale</article-title><source>Psychol Assess</source><year>2004</year><volume>16</volume><issue>1</issue><fpage>16</fpage><pub-id pub-id-type="doi">10.1037/1040-3590.16.1.16</pub-id><pub-id pub-id-type="pmid">15023089</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Zee</surname><given-names>KI</given-names></name><name><surname>Sanderman</surname><given-names>R</given-names></name><name><surname>Heyink</surname><given-names>JW</given-names></name><name><surname>de Haes</surname><given-names>H</given-names></name></person-group><article-title>Psychometric qualities of the RAND 36-Item Health Survey 1.0: a multidimensional measure of general health status</article-title><source>Int J Behav Med</source><year>1996</year><volume>3</volume><issue>2</issue><fpage>104</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1207/s15327558ijbm0302_2</pub-id><pub-id pub-id-type="pmid">16250758</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>van der Zee</surname><given-names>KI</given-names></name><name><surname>Sanderman</surname><given-names>R</given-names></name></person-group><source>Het meten van de algemene gezondheidstoestand met de RAND-36. Een handleiding [Measuring general health status with the RAND-36. Users manual]</source><year>1993</year><publisher-loc>Groningen</publisher-loc><publisher-name>Groningen Northern Center of Health Care Research</publisher-name></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallston</surname><given-names>KA</given-names></name><name><surname>Wallston</surname><given-names>BS</given-names></name><name><surname>DeVellis</surname><given-names>R</given-names></name></person-group><article-title>Development of the multidimensional health locus of control (MHLC) scales</article-title><source>Health Educ Behav</source><year>1978</year><volume>6</volume><issue>1</issue><fpage>160</fpage><lpage>170</lpage></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halfens</surname><given-names>R</given-names></name><name><surname>Philipsen</surname><given-names>H</given-names></name></person-group><article-title>Een gezondheidsspecifieke beheersingsorientatieschaal validiteit en betrouwbaarheid van de MHLC</article-title><source>T Soc Gezondheidsz</source><year>1988</year><volume>66</volume><fpage>399</fpage><lpage>403</lpage></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufman</surname><given-names>DJ</given-names></name><name><surname>Bollinger</surname><given-names>JM</given-names></name><name><surname>Dvoskin</surname><given-names>RL</given-names></name><name><surname>Scott</surname><given-names>JA</given-names></name></person-group><article-title>Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing</article-title><source>J Genet Couns</source><year>2012</year><volume>21</volume><issue>3</issue><fpage>413</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1007/s10897-012-9483-0</pub-id><pub-id pub-id-type="pmid">22278220</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carere</surname><given-names>DA</given-names></name><name><surname>Kraft</surname><given-names>P</given-names></name><name><surname>Kaphingst</surname><given-names>KA</given-names></name><name><surname>Roberts</surname><given-names>JS</given-names></name><name><surname>Green</surname><given-names>RC</given-names></name><name><surname>Group</surname><given-names>PGS</given-names></name></person-group><article-title>Consumers report lower confidence in their genetics knowledge following direct-to-consumer personal genomic testing</article-title><source>Genet Med</source><year>2015</year><volume>18</volume><issue>1</issue><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1038/gim.2015.34</pub-id><pub-id pub-id-type="pmid">25812042</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="other">Teeuw B, Schwarzer R, Jerusalem M: Dutch adaptation of the general self-efficacy scale. 1994. <ext-link ext-link-type="uri" xlink:href="http://userpage.fu-berlin.de/~health/dutch.htm">http://userpage.fu-berlin.de/~health/dutch.htm</ext-link>. Accessed 23 Oct 2015.</mixed-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>C</given-names></name><name><surname>Thoolen</surname><given-names>B</given-names></name><name><surname>Ridder</surname><given-names>D</given-names></name></person-group><article-title>Het meten van proactieve copingvaardigheden</article-title><source>PSEG</source><year>2008</year><volume>36</volume><issue>2</issue><fpage>81</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1007/BF03077476</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strijk</surname><given-names>JE</given-names></name><name><surname>Wendel-Vos</surname><given-names>GCW</given-names></name><name><surname>Picavet</surname><given-names>HSJ</given-names></name><name><surname>Hofstetter</surname><given-names>H</given-names></name><name><surname>Hildebrandt</surname><given-names>VH</given-names></name></person-group><article-title>Wat is vitaliteit en hoe is het te meten?</article-title><source>Tijdschrift voor gezondheidswetenschappen</source><year>2015</year><volume>93</volume><issue>1</issue><fpage>32</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1007/s12508-015-0013-y</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoerger</surname><given-names>M</given-names></name><name><surname>Quirk</surname><given-names>SW</given-names></name><name><surname>Weed</surname><given-names>NC</given-names></name></person-group><article-title>Development and validation of the Delaying Gratification Inventory</article-title><source>Psychol Assess</source><year>2011</year><volume>23</volume><issue>3</issue><fpage>725</fpage><pub-id pub-id-type="doi">10.1037/a0023286</pub-id><pub-id pub-id-type="pmid">21480721</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>LR</given-names></name></person-group><article-title>The development of markers for the Big-Five factor structure</article-title><source>Psychol Assess</source><year>1992</year><volume>4</volume><issue>1</issue><fpage>26</fpage><pub-id pub-id-type="doi">10.1037/1040-3590.4.1.26</pub-id></element-citation></ref></ref-list></back></article>